chr14-102930718-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_030943.4(AMN):c.*38G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,545,532 control chromosomes in the GnomAD database, including 353,428 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.65 ( 32317 hom., cov: 35)
Exomes 𝑓: 0.68 ( 321111 hom. )
Consequence
AMN
NM_030943.4 3_prime_UTR
NM_030943.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.447
Publications
11 publications found
Genes affected
AMN (HGNC:14604): (amnion associated transmembrane protein) The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008]
AMN Gene-Disease associations (from GenCC):
- Imerslund-Grasbeck syndrome type 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Imerslund-Grasbeck syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 14-102930718-G-C is Benign according to our data. Variant chr14-102930718-G-C is described in ClinVar as Benign. ClinVar VariationId is 1245489.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AMN | NM_030943.4 | c.*38G>C | 3_prime_UTR_variant | Exon 12 of 12 | ENST00000299155.10 | NP_112205.2 | ||
| AMN | NM_001425246.1 | c.*38G>C | 3_prime_UTR_variant | Exon 12 of 12 | NP_001412175.1 | |||
| AMN | XM_011537203.4 | c.*38G>C | 3_prime_UTR_variant | Exon 12 of 12 | XP_011535505.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.648 AC: 98587AN: 152072Hom.: 32297 Cov.: 35 show subpopulations
GnomAD3 genomes
AF:
AC:
98587
AN:
152072
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.681 AC: 101731AN: 149292 AF XY: 0.686 show subpopulations
GnomAD2 exomes
AF:
AC:
101731
AN:
149292
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.678 AC: 944785AN: 1393342Hom.: 321111 Cov.: 31 AF XY: 0.680 AC XY: 467846AN XY: 688328 show subpopulations
GnomAD4 exome
AF:
AC:
944785
AN:
1393342
Hom.:
Cov.:
31
AF XY:
AC XY:
467846
AN XY:
688328
show subpopulations
African (AFR)
AF:
AC:
17820
AN:
31614
American (AMR)
AF:
AC:
25333
AN:
36274
Ashkenazi Jewish (ASJ)
AF:
AC:
15757
AN:
25142
East Asian (EAS)
AF:
AC:
25531
AN:
36042
South Asian (SAS)
AF:
AC:
58610
AN:
79320
European-Finnish (FIN)
AF:
AC:
29460
AN:
45562
Middle Eastern (MID)
AF:
AC:
3323
AN:
4562
European-Non Finnish (NFE)
AF:
AC:
729962
AN:
1077050
Other (OTH)
AF:
AC:
38989
AN:
57776
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
15636
31272
46907
62543
78179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18986
37972
56958
75944
94930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.648 AC: 98662AN: 152190Hom.: 32317 Cov.: 35 AF XY: 0.652 AC XY: 48538AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
98662
AN:
152190
Hom.:
Cov.:
35
AF XY:
AC XY:
48538
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
23517
AN:
41524
American (AMR)
AF:
AC:
10881
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2216
AN:
3472
East Asian (EAS)
AF:
AC:
3619
AN:
5172
South Asian (SAS)
AF:
AC:
3553
AN:
4830
European-Finnish (FIN)
AF:
AC:
6676
AN:
10594
Middle Eastern (MID)
AF:
AC:
219
AN:
294
European-Non Finnish (NFE)
AF:
AC:
45976
AN:
67992
Other (OTH)
AF:
AC:
1420
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1857
3715
5572
7430
9287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.